Company: ATRA
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0000950170-25-006992
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                   
                                                                                             
      No.                                                                                    
     99.1      Press Release, dated January 21, 2025                                         
 ─────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                            Atara Biotherapeutics, Inc.            
  Date:      January 21, 2025      By:      /s/ AnhCo Nguyen                       
                                            AnhCo Nguyen, Ph. D.